Antitumor immunization of mothers delays tumor development in cancer-prone offspring

References

• De Flora S, Bonanni P. The prevention of infection-associated cancers. Carcinogenesis 2011; 32:787-95; PMID:21436188; http://dx.doi.org/10.1093/carcin/bgr054
   PubMed Web of Science ®Google Scholar
• Smit MA, Jaffee EM, Lutz ER. Cancer immunoprevention-the next frontier. Cancer Prev Res (Phila) 2014; 7:1072-80; PMID:25245763; http://dx.doi.org/10.1158/1940-6207.CAPR-14-0178
   PubMedGoogle Scholar
• Morphis LG, Gitlin D. Maturation of the maternofoetal transport system for human gamma-globulin in the mouse. Nature 1970; 228:573; PMID:5528694; http://dx.doi.org/10.1038/228573a0
   PubMed Web of Science ®Google Scholar
• Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007; 7:715-25; PMID:17703228; http://dx.doi.org/10.1038/nri2155
   PubMed Web of Science ®Google Scholar
• Hanson LA, Korotkova M, Lundin S, Haversen L, Silfverdal SA, Mattsby-Baltzer I, Strandvik B, Telemo E. The transfer of immunity from mother to child. Ann New York Acad Sci 2003; 987:199-206; PMID: 12727640; http://dx.doi.org/10.1111/j.1749-6632.2003.tb06049.x
   PubMedGoogle Scholar
• Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet 2007; 370:1947-59; PMID:17854885; http://dx.doi.org/10.1016/S0140-6736(07)61261-6
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555-64; PMID:18799552; http://dx.doi.org/10.1056/NEJMoa0708630
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged. MMWR 2011; 60(41):1424-6.
   Google Scholar
• Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol 2011; 11:865-72; PMID:22051890
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ. Vaccines and pregnancy: Past, present, and future. Sem Fet Neonat Med 2014; 19(3):161-9; PMID: 24355683
   PubMed Web of Science ®Google Scholar
• Botelho F, Clark DA. How might pregnancy immunize against breast cancer? Am J Reprod Immunol 1998; 39:279-83; PMID:9553653; http://dx.doi.org/10.1111/j.1600-0897.1998.tb00365.x
   PubMedGoogle Scholar
• Sandler B, Smirnoff P, Gurevich P, Zusman I. Transplacental tumor-preventive effects of polyclonal antibodies generated against the soluble 53 kDa antigen on mammary tumorigenesis in offspring. Oncol Rep 1999; 6:897-900; PMID:10373678
   PubMedGoogle Scholar
• Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention. Nat Rev Cancer 2006; 6:204-16; PMID:16498443; http://dx.doi.org/10.1038/nrc1815
   PubMed Web of Science ®Google Scholar
• Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL. 2011: the immune hallmarks of cancer. Can Immunol Immunother. CII 2011; 60:319-26 ; http://dx.doi.org/10.1007/s00262-010-0968-0
   PubMed Web of Science ®Google Scholar
• Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001; 2:127-37; PMID:11252954
   PubMed Web of Science ®Google Scholar
• Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, Di Carlo E, Pupa SM, De Giovanni C, Spadaro M, Curcio C, et al. Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Cancer Res 2004; 64:2858-64; PMID:15087404; http://dx.doi.org/10.1158/0008-5472.CAN-03-2962
   PubMed Web of Science ®Google Scholar
• Quaglino E, Rolla S, Iezzi M, Spadaro M, Musiani P, De Giovanni C, Lollini PL, Lanzardo S, Forni G, Sanges R, et al. Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. J Clin Invest 2004; 113:709-17; PMID:14991069; http://dx.doi.org/10.1172/JCI19850
   PubMed Web of Science ®Google Scholar
• Quaglino E, Mastini C, Iezzi M, Forni G, Musiani P, Klapper LN, Hardy B, Cavallo F. The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. Vaccine 2005; 23:3280-7; PMID:15837233; http://dx.doi.org/10.1016/j.vaccine.2005.01.086
   PubMed Web of Science ®Google Scholar
• Boggio K, Nicoletti G, Di Carlo E, Cavallo F, Landuzzi L, Melani C, Giovarelli M, Rossi I, Nanni P, De Giovanni C, et al. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 1998; 188:589-96; PMID:9687535; http://dx.doi.org/10.1084/jem.188.3.589
   PubMed Web of Science ®Google Scholar
• Quaglino E, Mastini C, Forni G, Cavallo F. ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas. Curr Protoc Immunol. 2008; 20 (20): 9.1-9. 10
   Google Scholar
• Rolla S, Nicolo C, Malinarich S, Orsini M, Forni G, Cavallo F, Ria F. Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice. J Immunol 2006; 177:7626-33; PMID:17114432; http://dx.doi.org/10.4049/jimmunol.177.11.7626
   PubMed Web of Science ®Google Scholar
• Rolla S, Ria F, Occhipinti S, Di Sante G, Iezzi M, Spadaro M, Nicolò C, Ambrosino E, Merighi IF, Musiani P, et al. Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy. J Immunol 2010; 184:6124-32; PMID:20435927; http://dx.doi.org/10.4049/jimmunol.0901215
   PubMed Web of Science ®Google Scholar
• Cavallo F, Offringa R, van der Burg SH, Forni G, Melief CJ. Vaccination for treatment and prevention of cancer in animal models. Adv Immunol 2006; 90:175-213; PMID:16730264; http://dx.doi.org/10.1016/S0065-2776(06)90005-4
   PubMed Web of Science ®Google Scholar
• Rovero S, Amici A, Di Carlo E, Bei R, Nanni P, Quaglino E, Porcedda P, Boggio K, Smorlesi A, Lollini PL, et al. DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol 2000; 165:5133-42; PMID:11046045; http://dx.doi.org/10.4049/jimmunol.165.9.5133
   PubMed Web of Science ®Google Scholar
• Iezzi M, Quaglino E, Amici A, Lollini PL, Forni G, Cavallo F. DNA vaccination against oncoantigens: a promise. Oncoimmunology 2012; 1:316-25; PMID:22737607; http://dx.doi.org/10.4161/onci.19127
   PubMed Web of Science ®Google Scholar
• Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmaki N, Levchenko T, Carlson LM, Musiani P, Iezzi M, Curcio C, et al. A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. Proc Natl Acad Sci U S A 2006; 103:9208-13; PMID:16754857; http://dx.doi.org/10.1073/pnas.0603110103
   PubMed Web of Science ®Google Scholar
• Arigoni M, Barutello G, Lanzardo S, Longo D, Aime S, Curcio C, Iezzi M, Zheng Y, Barkefors I, Holmgren L, et al. A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis 2012; 15:305-16; PMID:22426512; http://dx.doi.org/10.1007/s10456-012-9263-3
   PubMed Web of Science ®Google Scholar
• Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T. B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 1998; 4:627-30; PMID:9585241; http://dx.doi.org/10.1038/nm0598-627
   PubMed Web of Science ®Google Scholar
• Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood 2012; 119:5640-9; PMID:22535666; http://dx.doi.org/10.1182/blood-2012-01-380121
   PubMed Web of Science ®Google Scholar
• Clynes R, Takechi Y, Moroi Y, Houghton A, Ravetch JV. Fc receptors are required in passive and active immunity to melanoma. Proc Natl Acad Sci U S A 1998; 95:652-6; PMID:9435247; http://dx.doi.org/10.1073/pnas.95.2.652
   PubMed Web of Science ®Google Scholar
• Mosconi E, Rekima A, Seitz-Polski B, Kanda A, Fleury S, Tissandie E, Monteiro R, Dombrowicz DD, Julia V, Glaichenhaus N, et al. Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development. Mucosal Immunol 2010; 3:461-74; PMID:20485331; http://dx.doi.org/10.1038/mi.2010.23
   PubMed Web of Science ®Google Scholar
• Tse C, Gauchez AS, Jacot W, Lamy PJ. HER2 shedding and serum HER2 extracellular domain: biology and clinical utility in breast cancer. Cancer Treat Rev 2012; 38:133-42; PMID:21549508; http://dx.doi.org/10.1016/j.ctrv.2011.03.008
   PubMed Web of Science ®Google Scholar
• Grange C, Lanzardo S, Cavallo F, Camussi G, Bussolati B. Sca-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT transgenic mice. Neoplasia 2008; 10:1433-43; PMID:19048122
   PubMed Web of Science ®Google Scholar
• Conti L, Lanzardo S, Arigoni M, Antonazzo R, Radaelli E, Cantarella D, Calogero RA, Cavallo F. The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells. FASEB J 2013. 27(12):4731-44
   PubMed Web of Science ®Google Scholar
• Quaglino E, Mastini C, Amici A, Marchini C, Iezzi M, Lanzardo S, De Giovanni C, Montani M, Lollini PL, Masucci G, et al. A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. Cancer Res 2010; 70:2604-12; PMID:20332241; http://dx.doi.org/10.1158/0008-5472.CAN-09-2548
   PubMed Web of Science ®Google Scholar